Estimating Drug Costs: How do Manufacturer Net Prices Compare with Other Common US Price References?
Author:
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health,Health Policy,Pharmacology
Link
http://link.springer.com/article/10.1007/s40273-018-0667-9/fulltext.html
Reference26 articles.
1. Martin AB, Hartman M, Washington B, Catlin A, National Health Expenditure Accounts Team. National Health Spending: faster growth in 2015, as coverage expands and utilization increases. Health Aff. 2017;2017(36):166–76.
2. Keehan SP, Stone DA, Poisal JA, Cuckler GA, Sisko AM, Smith SD, et al. National health expenditure projections, 2016–25: price increases, aging push sector to 20% of economy. Health Aff. 2017;36:553–63.
3. Ward JW, Mermin JH. Simple, effective, but out of reach? Public health implications of HCV drugs. N Engl J Med. 2015;373:2678–80.
4. Hirsch BR, Balu S, Schulman KA. The impact of specialty pharmaceuticals as drivers of health care costs. Health Aff. 2014;33:1714–20.
5. Chhatwal J, Kanwal F, Roberts MSMS, Dunn MAMA. Cost-effectiveness and budget impact of hepatitis C virus treatment with sofosbuvir and ledipasvir in the United States. Ann Intern Med. 2015;162:397–406.
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cost per response analysis of deucravacitinib versus apremilast and first-line biologics among patients with moderate to severe plaque psoriasis in the United States;Journal of Dermatological Treatment;2024-06-24
2. Pharmacy Benefit Managers;JAMA Health Forum;2023-11-03
3. Comparison of Price Index Methods and Drug Price Inflation Estimates for Hepatitis C Virus Medications;JAMA Health Forum;2023-06-09
4. Comparison of US and EU Prices for Orphan Drugs in the Perspective of the Considered US Orphan Drugs Act Modifications and Discussed Price-Regulation Mechanisms Adjustments in US and European Union;International Journal of Environmental Research and Public Health;2022-09-24
5. Do Cost-Effectiveness Analyses Account for Drug Genericization? A Literature Review and Assessment of Implications;Value in Health;2022-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3